ArticleClinical pharmacokinetics2020

Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial.

Manuela Vay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.